Overview

A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma

Status:
Recruiting

Trial end date:
2024-08-11

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy and safety of mitoxantrone hydrochloride liposome injection combined with chidamide and azacitidine in the treatment of relapsed and refractory peripheral T-cell lymphoma

Phase:

Phase 2

Details

Lead Sponsor:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators:

Huizhou Municipal Central Hospital
Jinhua Central Hospital
Ningbo No. 1 Hospital

Treatments:

Azacitidine
Mitoxantrone